A Randomised, Placebo-Controlled, Double-Blind, Parallel Group Phase II Study to Assess the Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2013
At a glance
- Drugs ADC 3680 (Primary)
- Indications Allergic asthma
- Focus Adverse reactions; Biomarker; Pharmacokinetics; Therapeutic Use
- 17 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Jan 2012 Planned End Date changed from 1 Dec 2011 to 1 Feb 2012 as reported by ClinicalTrials.gov.
- 19 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.